Calcified Tissue International

, Volume 31, Issue 1, pp 215–223 | Cite as

Histological observations on the failure of rachitic rat bones to respond to 1,25/OH)2D3

  • J. A. Gallagher
  • D. E. M. Lawson


Rachitic rats, maintained on diets with low or normal P contents, were given daily intraperitoneal doses of 1,25(OH)2D3 or 25OHD3 at levels of 100 or 200 ng. Plasma chemistry was measured and the ash content and histological appearance of the bones investigated. Using labeled material it was shown that the dosing levels of 1,25(OH)2D3 employed ensured a higher than normal plasma concentration of that metabolite over the period between doses. 1,25(OH)2D3 was not as effective as 25OHD3 in raising bone ash or reducing the amount of osteoid. The difference between the effects of the metabolites was evident at both dietary P levels, but more marked at the higher P level. In contrast, the metabolites reduced the width of the epiphyseal plate to an approximately similar degree, and this is possibly the reason why there are discrepancies between previous reports of the effectiveness of 1,25(OH)2D3 compared with 25OHD3 or vitamin D3. Dosing with 1,25(OH)2D3 failed to maintain a constant plasma Pi value over the period between doses in animals fed the low P diet.

Key words

Bone 1,25(OH)2D3 25OHD3 Histology 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lawson, D.E.M.: Biochemical responses of the intestine to vitamin D. In D.E.M. Lawson (ed.): Vitamin D, pp. 167–200. Academic Press, London, 1978Google Scholar
  2. 2.
    Brickman, A.S., Sherrard, D.J., Jowsey, J., Singer, F.R., Baylink, D.J., Maloney, N., Massry, S.G., Norman, A.W., Coburn, J.W.: 1,25-Dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone level in uremic osteodystrophy, Arch. Intern. Med.134:883–888, 1974CrossRefPubMedGoogle Scholar
  3. 3.
    Reynolds, J.J.: The role of 1,25-dihydroxycholecalciferol in bone metabolism. In D. Fraser (ed.): The Metabolism and Function of Vitamin D, pp. 91–102. The Biochemical Society, London, 1974Google Scholar
  4. 4.
    Bordier, P., Rasmussen, H., Marie, P., Miravet, L., Gueris, J., Ryckwaert, A.: Vitamin D metabolites and bone mineralisation in man, J. Clin Endocrinol. Metab.46:284–294, 1978PubMedGoogle Scholar
  5. 5.
    Fournier, A., Bordier, P., Gueris, J., Luc Sebert, J., Marie, P., Ferriere, C., Bedrossian, J., DeLuca, H.F.: Comparison of 1 α-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralisation, Kidney Int.15:195–203, 1979Google Scholar
  6. 6.
    Ornoy, A., Goodwin, D., Noff, D., Edelstein, S.: 24,25-Dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation, Nature276:517–519, 1978CrossRefPubMedGoogle Scholar
  7. 7.
    Stern, P.H., Mavreas, T., Trummel, C.L., Schnoes, H.K., DeLuca, H.F.: Bone-resorbing activity of analogues of 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol: effects of side chain modifications and stereoisomerisation on responses of fetal rat bones in vitro, Mol. Pharmacol.12:879–886, 1976PubMedGoogle Scholar
  8. 8.
    Castillo, L., Tanaka, Y., DeLuca, H.F.: The mobilisation of bone mineral by 1,25-dihydroxyvitamin D3 in hypophosphatemic rats, Endocrinology97:995–999, 1975PubMedCrossRefGoogle Scholar
  9. 9.
    Kodicek, E., Lawson, D.E.M.: Vitamin D. In P. György, W.N. Pearson (eds.): The Vitamins, Chemistry, Physiology, Pathology, Methods, Vol. IV, pp. 211–244. Academic Press, New York, 1977Google Scholar
  10. 10.
    Tanaka, Y., Frank, H., DeLuca, H.F.: Role of 1,25-dihydroxycholecalciferol in calcification of bone and maintenance of serum calcium concentration in the rat, J. Nutr.102:1569–1578, 1972PubMedGoogle Scholar
  11. 11.
    Norman, A.W., Wong, R.G.: Biological activity of the vitamin D metabolite 1,25-hydroxycholecalciferol in chickens and rats, J. Nutr.102:1709–1718, 1972PubMedGoogle Scholar
  12. 12.
    McNutt, K.W., Haussler, M.R.: Nutritional effectiveness of dihydroxycholecalciferol in preventing rickets in chicks, J. Nutr.103:681–689, 1973PubMedGoogle Scholar
  13. 13.
    Bordier, P., Zingraff, J., Gueris, J., Jungers, P., Marie, P., Pechet, M., Rasmussen, H.: The effect of 1α(OH)D3 and 1α25(OH)2D3 on the bone in patients with renal osteodystrophy, Am. J. Med.64:101–107, 1978CrossRefPubMedGoogle Scholar
  14. 14.
    Numerof, P., Sassaman, H.L., Rodgers, A., Schaefer, A.E.: The use of radioactive phosphorus in the assay of vitamin D, J. Nutr.55:13–21, 1955PubMedGoogle Scholar
  15. 15.
    Edelstein, S., Charman, M., Lawson, D.E.M., Kodicek, E.: Competitive protein binding assay for 25-hydroxyvitamin D, Clin. Sci. Mol. Med.46:231–240, 1974PubMedGoogle Scholar
  16. 16.
    Fiske, C.H., Subbarow, Y.: The colourimetric determination of phosphorus, J. Biol. Chem.66:375–381, 1925Google Scholar
  17. 17.
    Bessey, O.A., Lowry, O.H., Brock, M.J.: A method for the rapid determination of alkaline phosphatase with 5 mm3 of serum, J. Biol. Chem.164:321–329, 1946Google Scholar
  18. 18.
    Tripp, E.J., MacKay, E.H.: Silver staining of bone prior to decalcification for quantitative determination of osteoid in sections, Stain Technol.47:129–136, 1972PubMedGoogle Scholar
  19. 19.
    Merz, W.A., Schenk, R.K.: Quantitative structural analysis of human cancellous bone, Acta Anat. (Basel)75:54–66, 1970Google Scholar
  20. 20.
    Steenbock, H., Herting, D.C.: Vitamin D and growth, J. Nutr.57:449–468, 1974Google Scholar
  21. 21.
    Jones, J.H.: The production of hypercalcaemia with small amounts of vitamin D, J. Nutr.28:7–16, 1944Google Scholar
  22. 22.
    Schneider, H., Steenbock, H.: A low phosphorus diet and the response of rats to vitamin D2, J. Biol. Chem.128:159–171, 1939Google Scholar
  23. 23.
    Rosenblum, I.Y.: The effect of EHDP on mineral and organic components of rat bone, Calcif. Tissue Res.16:239–245, 1974CrossRefPubMedGoogle Scholar
  24. 24.
    Wes Pike, J., Toverud, S., Boass, A., McCain, T., Haussler, M.R.: Circulating 1,25(OH)2D during physiological states of calcium stress. In A.W. Norman, K. Schaefer, J.W. Coburn, H.F. DeLuca, D. Fraser, H.G. Grigoleit, D.V. Herrath (eds.): Vitamin D: Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism, pp. 187–189. Walter de Gruyter, Berlin, 1977Google Scholar
  25. 25.
    Weisbrode, S.E., Capen, C.C., Norman, A.W.: Ultrastructural evaluation of the effects of 1,25(OH)2D3 on bone of thyroparathyroidectomised rats fed a low calcium diet, Am. J. Pathol.92:459–472, 1978PubMedGoogle Scholar
  26. 26.
    Hartenbower, D.L., Stanley, T.M., Coburn, J.W., Norman, A.W.: Serum and renal histological changes in the rat following administration of toxic amounts of 1,25(OH)2D3. In A.W. Norman, K. Schaefer, J.W. Coburn, H.F. DeLuca, D. Fraser, H.G. Grigoleit, D.V. Herrath (eds.): Vitamin D: Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism, pp. 587–589. Walter de Gruyter, Berlin, 1977Google Scholar
  27. 27.
    Eastwood, J.B., Bordier, P.J., Clarkson, E.M., Tun Chot, S., De Wardener, H.E.: The contrasting effects on bone histology of vitamin D and of calcium carbonate in the osteomalacia of chronic renal failure, Clin. Sci. Mol. Med.47:23–42, 1974PubMedGoogle Scholar
  28. 28.
    Ivey, J.L., Morey, E.R., Liu, C.C., Rader, J.I., Baylink, D.J.: Effects of vitamin D and its metabolites on bone. In A.W. Norman, K. Schaefer, J.W. Coburn, H.F. DeLuca, D. Fraser, H.G. Grigoleit, D.V. Herrath (Eds): Vitamin D Biochemical, Chemical and Clinical aspects related to calcium metabolism pp 587–589. Walter de Gruyter, Berlin, New York, 1977.Google Scholar
  29. 29.
    Fourman, P., Royer, P.: Calcium Metabolism and Bone, pp. 292–293. Blackwell Scientific Publications. Oxford, 1968Google Scholar

Copyright information

© Springer-Verlag 1980

Authors and Affiliations

  • J. A. Gallagher
    • 1
  • D. E. M. Lawson
    • 1
  1. 1.Dunn Nutritional LaboratoryUniversity of Cambridge, and Medical Research CouncilCambridgeEngland

Personalised recommendations